Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
Seed Therapeutics has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
Seed Therapeutics's investors include Eisai.
Seed Therapeutics is headquartered in King Of Prussia, United States.
Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
Seed Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Seed Therapeutics — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/seed-therapeutics. Accessed November 14, 2026.
VCBacked. (2024). Seed Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/seed-therapeutics
{{cite web |title=Seed Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/seed-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Seed Therapeutics? Request a listing update